Results 11 to 20 of about 15,079 (253)

Membranous nephropathy [PDF]

Brazilian Journal of Nephrology, 2023
Membranous nephropathy is a glomerulopathy, which main affected target is the podocyte, and has consequences on the glomerular basement membrane. It is more common in adults, especially over 50 years of age.
Márcio Dantas, Lázaro Bruno Borges Silva, Barbhara Thaís Maciel Pontes, Marlene Antônia dos Reis, Patrícia Soares Nunes de Lima, Miguel Moysés Neto   +5 more
doaj   +4 more sources

Rituximab in Membranous Nephropathy [PDF]

Kidney International Reports, 2021
Membranous nephropathy (MN) is the most common cause of primary nephrotic syndrome among adults. The identification of phospholipase A2 receptor (PLA2R) as target antigen in most patients changed the management of MN dramatically, and provided a rationale for B-cell depleting agents such as rituximab. The efficacy of rituximab in inducing remission has
Philipp Gauckler, Jae Il Shin, Federico Alberici, Vincent Audard, Annette Bruchfeld, Martin Busch, Chee Kay Cheung, Matija Crnogorac, Elisa Delbarba, Kathrin Eller, Stanislas Faguer, Kresimir Galesic, Siân Griffin, Martijn W.F. van den Hoogen, Zdenka Hrušková, Anushya Jeyabalan, Alexandre Karras, Catherine King, Harbir Singh Kohli, Gert Mayer, Rutger Maas, Masahiro Muto, Sergey Moiseev, Balazs Odler, Ruth J. Pepper, Luis F. Quintana, Jai Radhakrishnan, Raja Ramachandran, Alan D. Salama, Ulf Schönermarck, Mårten Segelmark, Lee Smith, Vladimír Tesař, Jack Wetzels, Lisa Willcocks, Martin Windpessl, Ladan Zand, Reza Zonozi, Andreas Kronbichler, Philipp Gauckler, Jae Il Shin, Federico Alberici, Vincent Audard, Annette Bruchfeld, Martin Busch, Chee Kay Cheung, Matija Crnogorac, Elisa Delbarba, Kathrin Eller, Stanislas Faguer, Kresimir Galesic, Siân Griffin, Martijn W.F. van den Hoogen, Zdenka Hrušková, Anushya Jeyabalan, Alexandre Karras, Catherine King, Harbir Singh Kohli, Gert Mayer, Rutger Maas, Masahiro Muto, Sergey Moiseev, Balazs Odler, Ruth J. Pepper, Luis F. Quintana, Jai Radhakrishnan, Raja Ramachandran, Alan D. Salama, Ulf Schönermarck, Mårten Segelmark, Lee Smith, Vladimír Tesař, Jack Wetzels, Lisa Willcocks, Martin Windpessl, Ladan Zand, Reza Zonozi, Andreas Kronbichler   +77 more
openaire   +12 more sources

Advances in Membranous Nephropathy [PDF]

Journal of Clinical Medicine, 2021
Membranous nephropathy (MN) is a rare auto-immune disease where the glomerulus is targeted by circulating auto-antibodies mostly against podocyte antigens, which results in the formation of electron-dense immune complexes, activation of complement and massive proteinuria.
Ronco, Pierre, Plaisier, Emmanuelle, Debiec, Hanna   +2 more
openaire   +3 more sources

Membranous Nephropathy [PDF]

Journal of the Royal College of Physicians of London, 1997
link_to_subscribed_fulltext
Simon C Satchell, Peter W Mathieson
openaire   +4 more sources

Treatment of membranous nephropathy [PDF]

Nephrology Dialysis Transplantation, 2001
Several therapeutic approaches have been tried in patients with membranous nephropathy. Corticosteroids have been largely used, but a meta-analysis of the available controlled trials did not show any benefit of corticosteroids either in favouring remission of the nephrotic syndrome or in preventing renal dysfunction.
Passerini Patrizia, Ponticelli Claudio
openaire   +4 more sources

IMMUNODIAGNOSIS IN MEMBRANOUS NEPHROPATHY

Wiadomości Lekarskie, 2020
One of the diseases leading to chronic end-stage renal disease is membranous nephropathy (MN). The main cause of this disease is the formation of antibodies to foreign and native antigens. Membranous nephropathy can be conventionally divided into 2 types: primary form (when the primary disease is unknown) and secondary form.
Magdalena, Ratajczak, Ewa, Poleszak, Tomasz, Chrościcki   +2 more
openaire   +3 more sources

Lupus Membranous Nephropathy [PDF]

Glomerular Diseases, 2021
<b><i>Background:</i></b> Lupus membranous nephropathy (LMN) is a rare disease, usually associated with nephrotic syndrome. <b><i>Methods:</i></b> We reviewed the literature by searching for the following terms on Pubmed.gov: lupus nephritis, membranous nephropathy (MN), lupus membranous nephropathy ...
Ponticelli, Claudio, Moroni, Gabriella, Fornoni, Alessia   +2 more
openaire   +2 more sources

Hyperlipidemia in membranous nephropathy. [PDF]

Clin Kidney J
ABSTRACT Membranous nephropathy (MN) is a common glomerular disease leading to nephrotic syndrome in adults, clinically characterized by massive proteinuria, hypoalbuminemia, and prominent hyperlipidemia. Growing evidence suggests that hyperlipidemia is not merely a secondary consequence of MN, but may also play a critical role in the
Zhang M, Liu WL, Xu G, Dong L.
europepmc   +4 more sources

Immunology of membranous nephropathy [PDF]

F1000Research, 2019
Accounting for about 20 to 50% of cases of primary nephrotic syndrome, membranous nephropathy (MN) is the leading cause of nephrotic syndrome in adults. A rat model created nearly 60 years ago to research the primary MN disorder, Heymann nephritis, has provided us with a plethora of important information.
Shin'ichi Akiyama, Enyu Imai, Shoichi Maruyama   +2 more
openaire   +2 more sources

The Mayo Clinic consensus report on membranous nephropathy; a promising step toward better treating the disease [PDF]

Journal of Nephropharmacology
Membranous nephropathy is an immune complex disease caused by subepithelial deposits. The pathological manifestations of membranous nephropathy are considered by the creation of immune complexes in the epithelial cells of the glomerular basement membrane.
Samaneh Zandifar, Leila Alem, Azadeh Khayyat, Mohammad Ali Esmaeil Pour   +3 more
doaj   +1 more source